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ABSTRACT
This study was conducted to explore whether supplementation of zinc to children during persistent diar-
rhoea has any subsequent effect on morbidity and growth. A prospective follow-up study was conducted 
among children, aged 3-24 months, with persistent diarrhoea, who participated earlier in a double-blind 
randomized placebo-controlled trial. During persistent diarrhoea, children were randomly allocated to 
receive either zinc in multivitamin syrup or only multivitamin syrup for two weeks. After recovering 
from diarrhoea, 76 children in the multi-vitamin syrup and 78 children in the zinc plus multivitamin 
syrup group were followed up for subsequent morbidity and growth. Weekly morbidity and two-weekly 
anthropometric data were collected for the subsequent 12 weeks. Data showed that episodes and dura-
tion of diarrhoea were reduced by 38% and 44% respectively with supplementation of zinc. There was 
no significant difference in the incidence or duration of respiratory tract infection between the zinc-
supplemented and the non-supplemented group. Improved linear growth was observed in underweight 
children (weight-for-age <70% of the National Center for Health Statistics standard) who received zinc 
compared to those who did not receive.
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INTRODUCTION
Diarrhoea is an important factor to precipitate malnutri-
tion in children, and a frequent cause of growth faltering 
(1,2). Associated zinc deficiency is likely to augment 
the process of growth faltering. Children with protein-
energy malnutrition are often deficient in essential mi-
cronutrients, including zinc. Results of studies suggest 
that zinc deficiency is likely to be a causal factor of in-
creased morbidity (3) and growth faltering in malnour-
ished children (4,5). 
  Zinc supplementation reduced the incidence (6), du-
ration, and severity of diarrhoea in children (7) and had a 
protective effect on diarrhoea and respiratory infections 
(8).  A study in India documented that zinc supplementa-
tion reduced the incidence of persistent diarrhoea by 73% 
in children with lower serum zinc concentrations (<7.65 
µmol/L). Results of a study also showed a significant re-
duction in episodes of dysentery in male children (6). It 
is likely that episodes of diarrhoea result in a further zinc-
deficient state in malnourished children due to the higher 
loss of zinc in persistent diarrhoea stool, which may lead 
to increased morbidity. Loss of zinc in diarrhoea stool 
may be as high as 159 µg/kg.day in acute diarrhoea (9) 
and 300 µg/kg.day in persistent diarrhoea (10).Several studies have shown the positive effect of zinc 
supplementation on growth among stunted (11-13) and 
malnourished children. Recently, result of a meta-analy-
sis of 25 studies showed that zinc supplementation in-
creased height and weight in children (14). Results of 
another study showed that zinc supplementation for five 
months (10 mg/d) increased both weight and height sig-
nificantly in the zinc-supplemented group compared to 
the non-supplemented group (11). During nutritional re-
habilitation, severely-malnourished children had a great-
er gain in length with zinc supplementation in many 
countries, including Bangladesh (15). Supplementation 
of zinc has also led to better growth rate in preterm and 
full-term healthy infants compared to non-supplement-
ed ones (4).   
  Although some information is available on the effect 
of zinc supplementation on subsequent morbidity and 
growth in children with acute diarrhoea (13), there is 
no information about any subsequent effect of zinc sup-
plementation on morbidity and growth of children who 
received zinc for two weeks only during persistent diar-
rhoea. 
  We, therefore, undertook a study to follow up children 
who received zinc during persistent diarrhoea to explore 
whether there is any subsequent effect of zinc supplemen-
tation on morbidity and growth after discharge from 
hospital. It is hypothesized that supplementation of zinc 
during persistent diarrhoea will reduce subsequent mor-
bidity and growth faltering in malnourished children.
MATERIALS AND METHODS
Study design
A prospective follow-up study was conducted among 
children aged 3-24 months, who participated earlier in 
a double-blind randomized placebo-controlled trial for 
clinical recovery from persistent diarrhoea to explore 
the impact of zinc supplementation on morbidity and 
growth after discharge from hospital.
Participants
The participants were children of both sexes, aged 
3-24 months, who were previously treated with zinc 
or placebo during persistent diarrhoea (16). Children 
who attended the Clinical Research and Service Centre 
(now Dhaka Hospital) of ICDDR,B, during 1987-1989, 
were included in the study. Children from urban and 
peri-urban areas within the 20-km radius of the Centre 
only were considered for the study. The exclusion crite-
ria included the presence of any severe systemic infec-
tion, temperature more than 38 °C, and pedal oedema. 
Selection of subjects 
Initially, 190 children with persistent diarrhoea were 
enrolled into the clinical study. Of these children, 154 
children were available for the morbidity and growth 
follow-up study. The remaining 36 children (17 from the 
zinc group and 19 from the placebo group) were dropped 
from the study for various reasons (Fig. 1). 
Intervention: During persistent diarrhoea, each subject 
received either 20 mg of elemental zinc in a multivita-
min syrup daily or multivitamin alone in three-divided 
doses for two weeks. Syrup, manufactured by ACME 
Laboratories Limited, Dhaka, Bangladesh, was started 
immediately after collection of baseline blood and stool 
samples for laboratory investigations. During hospitali-
zation, the syrup was administered by nurses and after 
discharge from the hospital by mothers trained during 
their hospital stay. Children were not discharged from 
the hospital until recovery, i.e. not before passing soft 
stool (except left without medical advice). After dis-
charge from the hospital, trained health workers ensured 
daily intake of syrup through checking the remaining 
portion of syrup in the bottle during home-visits on al-
ternate days.
Anthropometry: After discharge from the hospital, 
children were followed up at home once a week for the 
first month and then fortnightly for the next two months. 
During follow-up, body-weight was obtained using a 
Salter scale (UK) with an accuracy of 100 g. Supine-
length was measured with a locally-constructed length 
board with a precision of 1 mm. All instruments were 
standardized everyday in the morning before measure-
ments. For accuracy in weight and length, three meas-
urements were obtained, and their average was accepted 
as the correct measurement. The nutritional status was 
determined as percent of the median National Center for 
Health Statistics (NCHS) standard (17). Underweight 
was  defined  as  weight-for-age  ≤70%  of  the  median 
NCHS standard. Weekly morbidity data were collected 
for 12 weeks using precoded questionnaires. During 
weekly home-visits, mothers were asked about the ex-
act day of the beginning of any illness, its duration, and 
the day of recovery. Children who were not available 
for follow-up on the scheduled date were visited on the 
following days. 
Morbidity: Morbidity data were collected weekly 
during the first four weeks of follow-up and then two 
weekly up to 12 weeks using the recall method. A coded 
questionnaire was used for determining the number of 
episodes and the duration of each episode. The dura-
tion of episode was determined counting the days be-
tween onset of illness and recovery as described by the 
mother. 
Ethical consent: The Ethical Review Committee of 
ICDDR,B approved the study, and a written informed 
consent was obtained from parents of all children.
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Fig. 1. Flow-diagram of selection of subjects 
*LAMA:Left against medical advice
95 (zinc)  95 (placebo)
9 LAMA and lost to
follow-up
14 LAMA and lost to
follow-up
76 were available for
follow-up
78 were available for
follow-up 
Definitions 
Diarrhoea: Diarrhoea was defined as three or more liq-
uid, watery or mucoid stools in 24 hours or any number 
of stools containing blood. A new episode of diarrhoea 
was separated from any previous episode by an interval 
of at least 48 hours with no diarrhoea. 
Upper respiratory tract infection: Upper respiratory 
tract infection was defined by the presence of cough, 
nasal discharge, and respiratory rate less than 50 or 40 
in infants aged less than one year and children aged 1-2 
year(s) respectively. 
Lower respiratory tract infection: Lower respira-
tory tract infection was defined by the presence of fast 
breathing (respiratory rate more than 50 per minute in 
infants aged less then one year, >40 per minute in infants 
aged 1-2 year(s), difficulty in breathing with cough, and 
body temperature above 38 ºC or presence of chest in-
drawing. 
Laboratory investigations
Serum zinc: Venous blood was collected between 9 
and 11 am after initial correction of dehydration on the 
day of selection of subjects before beginning of supple-
mentation and again at the end of two-week’s supple-
mentation, in nitric acid-washed zinc-free glass vials for 
estimation of serum zinc. Serum zinc was measured us-
ing an atomic absorption spectrophotometer (AAS, Per-
kin-Elmer Model 3100) according to Prasad et al. (18). 
Statistical analysis
Subjects were taken for growth and morbidity analysis 
from the beginning of follow-up. The effect of zinc sup-
plementation was compared between the groups. As the 
effect of zinc is more pronounced in malnourished chil-
dren, subgroup analysis was restricted to underweight 
children  (≤70%  weigh-for-age).  Student’s  t-test  was 
used for comparing the means of net gain in length be-
tween the two groups. Gain in weight and length was 
compared between the groups using the t-test. The epi-
sodes and duration of diarrhoea and respiratory infec-
tions were compared between the groups using t-tests. 
Data were analyzed using the SPSS/PC+ and NCHS 
statistical packages. Statistical significance was accept-
ed at 5% probability level. 
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In total, 154 children were followed up for 12 weeks af-
ter two weeks of zinc supplementation during persistent 
diarrhoea. Of the 154 children, 76 received multivita-
min syrup only, and 78 received zinc with multivitamin 
syrup during persistent diarrhoea before enrollment into 
the follow-up study. Seven (5%) children  did not com-
plete the 12-week follow-up study period due to migra-
tion. Four subjects migrated from the placebo group, 
and three subjects migrated from the zinc group. Those 
who migrated had comparable baseline characteristics, 
such as anthropometric measurements and initial dura-
tion of diarrhoea with the remaining children of their 
respective trial group. Children in the placebo and zinc-
supplemented groups were comparable on admission for 
age, sex, duration of diarrhoea, nutritional status, and 
levels of serum zinc (Table 1). The subjects were also 
comparable by their feeding status; an equal proportion 
of children was breastfed in the control or zinc group 
(49% vs 51%, p=0.78, data not shown). Table 2 shows 
baseline comparison in characteristics of the under-
weight subgroup.  
  During the three-month follow-up period, 26 of 
the 78 children (33%) in the zinc group experienced at 
least one episode of diarrhoea compared to 33 of the 
placebo group (33/76; 43%). The mean diarrhoeal epi-
sodes were significantly less in the zinc-supplemented 
children compared to the control children (0.53±0.10, vs 
0.86±0.14, p<0.05) (Table 3). The mean duration of sub-
sequent diarrhoea episodes in the zinc group was 44% 
shorter compared to that of the control group (1.9±0.40 
vs 3.4±0.62 days, p<0.05) (Table 3). Zinc supplementa-
tion was not associated with the incidence or duration of 
respiratory infections during the follow-up period. 
  During the subsequent 12 weeks of follow-up, cu-
mulative gain in length was comparable between the 
zinc-supplemented and the control children when data 
from all patients were compared (35.7±12.9 mm vs 
31.2±12.6, p=0.6; data not shown). Hence, when the gain 
in length was compared among underweight children 
(weight-for-age, ≤70% of NCHS, n=68), a greater cu-
mulative gain in length (24%) was observed in the zinc-
supplemented group (30.2±10.0 vs 24.4±10.8, p<0.03) 
compared to the control group. The accelerated length 
velocity of underweight subjects continued from the 
second week to 10th week of follow-up (p=0.03) (Fig. 
2). There was no significant difference in cumulative gain 
in body-weight between the zinc and the control group 
as a whole or in the subgroups.
Mortality: In total, 13 children died during the 12- weeks 
period. Of these children, six died in the zinc-supple-
mented group, and seven died in the placebo group. Of   
Table 1. Comparison of selected baseline characteristics of study subjects (mean±SD)
Characteristics Zinc (n=78) Placebo (n=76) p value
Age (months) 7.0±3.0 8.0±4.0 0.31
Sex (M/F) 56/22 45/31 0.10
Weight-for-age (z-score) -2.46±1.0 -2.44±1.2 0.18
Height-for-age (z-score) -1.64±1.3 -1.44±1.1 0.29
Weight-for-height (z-score) -1.81±1.0 -1.68±0.86 0.06
MUAC (cm) 11.7±1.0 11.6±1.0 0.71
Duration (days) of diarrhoea on admission 23±10 22±12 0.73
Serum zinc (µmol/L) 13.4±4.8 13.2±4.1 0.10
MUAC=Mid-upper arm circumference; F=Female; M=Male; SD=Standard deviation
Table 2. Baseline characteristics of underweight children (weight-for-age <70% of  NCHS median)
Characteristics Zinc (n=36)
mean±SD
Placebo (n=32)
mean±SD p value
Age (months) 7.6±3.1 9.3±3.7 0.04
Weight-for-age (z-score) -3.3±0.7 -3.6±0.8 0.08
Height-for-age (z-score) -2.6±0.8 -2.3±0.1 0.18
Serum zinc (µmol/L) 13.9±4.5 13.4±3.8 0.62
Diarrhoea on admission (duration in days) 25.0±10.9 22.0±9.9 0.24
NCHS=National Center for Health Statistics; SD=Standard deviation
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Fig. 2. Impact of zinc supplementation on linear growth among lighter children (weight-for-age ≤70%)
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these deaths, two died in week 1, four died in week 2, 
three died in week 3, one died in week 5, and three died 
in week 6. No deaths occurred between week 6 and 12. 
Causes of death diagnosed by verbal autopsy included 
bronchopneumonia, septicaemia, and severe diarrhoea. 
Two patients with persistent diarrhoea returned to the 
hospital for treatment, and both of them had both diar-
rhoea and pneumonia, and one died of severe intracta-
ble diarrhoea.
Table 3. Comparison of illness episodes and duration between groups in patients with persistent diarrhoea 
during the follow-up (mean±SEM)
Illness Zinc (n=36)
mean±SD
Placebo (n=32)
mean±SD p value
Diarrhoea (no. of episodes)   0.53±0.10    0.86±0.14 0.05
Duration (days) of diarrhoea 1.9±0.40  3.4±0.62 0.05
RTI (no. of episodes) 1.42±0.14    1.54±0.86 0.55
Duration (days) of RTI Student’s t-test 12.4±1.64 12.0±1.72 0.92
RTI=Respiratory tract infection; SD=Standard deviation; SEM=Standard error of the mean
The clinical benefits of zinc supplementation in these 
children with persistent diarrhoea were early recovery 
especially in underweight and male children described 
earlier (16). A significantly higher number of children 
also dropped out from the placebo group due to pro-
longed suffering. Results of our earlier studies in acute 
diarrhoea showed the benefits of zinc supplementation 
to malnourished children, such as reduced stool output 
and reduced the duration of recovery (19). Home fol-
low-up of those acute diarrhoea children after discharge 
showed subsequent benefit of increased linear growth 
among those who received zinc during diarrhoea (13). 
The follow-up also showed significantly reduced respi-
ratory tract infection in stunted children who received 
zinc during acute diarrhoea.
DISCUSSION
The study examined the effect of supplementation of 
zinc in patients with persistent diarrhoea on the reduc-
tion of subsequent morbidity due to diarrhoea and respi-
ratory tract infections and growth faltering. 
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carry-over benefits of zinc supplementation in addition 
to early recovery of persistent diarrhoea, which extended 
for about three months after supplementation.  
  The zinc-supplemented patients with persistent di-
arrhoea had fewer attacks of diarrhoea, possibly due to 
their better immune status after supplementation of zinc. 
Diarrhoea illness may be prolonged by factors that 
cause injury to intestinal mucosa or delay in repair 
of mucosa. Our earlier study demonstrated that zinc has 
profound effects on intestinal epithelial tissue in respect 
of growth of mucosal tissue and ultrastructures which 
are directly related to water and electrolyte transport 
(20). 
  In the present study, reduction in diarrhoea at-
tacks (38%) and reduction in the duration of episodes 
(44%) in the zinc-supplemented children have a similar-
ity with a community-based study conducted in India 
where children with acute diarrhoea had a 7% reduction 
in probability of continuing diarrhoea beyond seven 
days and 30% reduction in subsequent diarrhoea epi-
sodes with zinc supplementation (7). Our results have 
further confirmed results of a zinc-supplementation 
study on growth-retarded Vietnamese children who 
had a three-fold decrease in the incident of diarrhoea 
and a 2.5-fold decrease in respiratory infections during 
a five-month period of zinc supplementation (11). The 
supplementation of zinc in that study, however, was 
continuous and for a much longer period compared to 
our study. The effect of reduction in diarrhoea episodes 
was about 1.5-fold in our study, and the decrease in du-
ration of episodes was also similar. The results of the 
present study are consistent with the results of stud-
ies conducted in free-living children having a reduction 
in diarrhoeal illness following zinc supplementation in 
Mexico (21) and Guatemala (22). In the Mexican study, 
both diarrhoea and respiratory infection decreased sig-
nificantly with a 20-mg daily zinc supplementation for 
12 months compared to placebo, but the effect was less 
pronounced in respiratory infections compared to diar-
rhoea (23).  
  The effect of zinc on linear growth was not evident 
when all children (both malnourished and well-nour-
ished) of both the groups were compared; it was, how-
ever, evident in more malnourished children. Several 
points are to be considered in this respect, such as zinc 
increases growth in a zinc-deficient state acting as a 
rate-limiting factor, and a larger proportion (60%) of 
our subjects were malnourished. The carry-over growth 
effect of zinc during short supplementation in persist-
ent diarrhoea was reflected in the more-deficient group, 
i.e. underweight subjects, but not in the well-nourished 
children.
  The zinc-supplemented children had reduced epi-
sodes of diarrhoea and, at the same time, had additional 
gain in length. Although diarrhoea is a potential con-
founder on the effect of zinc on growth in this study, 
the effect of zinc supplementation on gain in length was 
independent of the effect of zinc on diarrhoea. Sup-
plemental zinc had been exhausted during growth as a 
rate-limiting factor and did not support increased growth 
after 10 weeks. Growth-retarded Vietnamese children 
had increased growth with zinc supplementation for 
three months with increased insulin-like growth factor I 
(11). This result suggests that zinc has a particular role 
in stimulating growth by activating growth hormone.   
The mechanism of zinc to facilitate skeletal growth is 
not fully understood, but alkaline phosphatase is a zinc 
metalloenzyme, which aids in bone growth. Zinc also 
participates in bone growth via enhanced mineraliza-
tion (24). 
  Data on gain in length during supplementation of 
zinc are dependent on the level of malnutrition in 
the children and the dietary quality. Results of studies 
of zinc supplementation during rehabilitation of severe-
ly-malnourished children showed gain in length when 
children were fed high-energy and high-protein diets 
(15,25,26). In  our study, children went home  with ad-
vice to take the usual home-diet during the follow-up 
period, and they were not given zinc during the fol-
low-up period. Plausible causes of failure to increase 
gain in body-weight in our study would include that the 
children were suffering from persistent diarrhoea with 
significant malabsorption of nutrients (27). Zinc is ex-
creted in diarrhoeal stool leading to a risk of a negative 
zinc balance (9). 
  No difference in respiratory infections was, howev-
er, observed between the two groups. The supplemen-
tation of zinc was not continued during the follow-up 
period to see the effect of supplementation as in oth-
er studies. It was rather explored whether there was any 
carry-over effect of zinc during the subsequent period 
after persistent diarrhoea. Even if there were any carry-
over effect of zinc on respiratory infection, our sample 
size was not adequate to detect the significant differ-
ence between the zinc-supplemented and the non-sup-
plemented groups. 
  The results of our study indicate that supplementa-
tion of zinc to children during persistent diarrhoea has 
the additional benefit of reducing subsequent diarrhoea 
episodes and their duration in all children for about 
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underweight children. These results have a particular 
significance for public-health policy. We, therefore, rec-
ommend supplementation of zinc at a dose of 20 mg/day 
for at least two weeks in all children during persistent 
diarrhoea. Zinc mixed with oral rehydration solution 
(ORS) could be another possibility for supplementation 
of zinc during diarrhoea, but the appropriate dose of 
zinc per litre of ORS needs to be determined through a 
well-designed controlled clinical trial. 
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